ArticleClinics (Sao Paulo, Brazil)2026
Relationship between metabolically unhealthy obesity and chronic obstructive pulmonary disease among U.S. adults: Evidence from NHANES 1999-2018.
Article in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis research aimed to examine the association of Metabolically Unhealthy Obesity (MUO) with the prevalence of Chronic Obstructive Pulmonary Disease (COPD).
methodsThe present research applied a cross-sectional design, and participants from the National Health and Nutrition Examination Survey 1999-2018 were enrolled. The association between metabolically healthy and unhealthy obesity phenotypes and COPD was examined through multivariable logistic regression analyses.
resultsIn total, 28,401 individuals were enrolled, among whom 2403 had COPD. After controlling for confounders, Body Mass Index (BMI) exhibited a positive association with the prevalence of COPD (OR = 1.04, 95% CI: 1.03-1.05, p < 0.001). MUO was associated with significantly elevated prevalence of COPD compared with Metabolically Healthy Normal Weight (MHNW) (OR = 2.02, 95% CI 1.51‒2.70). BMI was linearly associated with COPD in the metabolically healthy group (P-non-linear = 0.276), whereas in the metabolically unhealthy group, the association was nonlinear (P-non-linear = 0.002). According to receiver operating characteristic curve analysis, the Area Under the Curve (AUC) of BMI for diagnosing COPD was 0.735 (95% CI 0.695-0.775) in metabolically healthy individuals and 0.747 (95% CI 0.736-0.757) in metabolically unhealthy individuals.
conclusionMUO is associated with a higher prevalence of COPD in U.S. adults. Regardless of metabolic health status, obesity is associated with a higher prevalence of COPD. These findings suggest that maintaining a healthy body weight through lifestyle interventions may be beneficial across all populations, even providing additional benefits among metabolically healthy individuals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.